These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 37923683
21. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m). Carlsten C, Swenson ER, Ruoss S. High Alt Med Biol; 2004; 5(1):33-9. PubMed ID: 15072715 [Abstract] [Full Text] [Related]
22. Language used in Lake Louise Scoring System underestimates symptoms of acute mountain sickness in 4- to 11-year-old children. Southard A, Niermeyer S, Yaron M. High Alt Med Biol; 2007; 8(2):124-30. PubMed ID: 17584006 [Abstract] [Full Text] [Related]
25. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). Gertsch JH, Basnyat B, Johnson EW, Onopa J, Holck PS. BMJ; 2004 Apr 03; 328(7443):797. PubMed ID: 15070635 [Abstract] [Full Text] [Related]
26. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial. Jafarian S, Gorouhi F, Salimi S, Lotfi J. Ann Neurol; 2007 Sep 03; 62(3):273-7. PubMed ID: 17557349 [Abstract] [Full Text] [Related]
27. Twice-daily assessment of trekkers on Kilimanjaro's Machame route to evaluate the incidence and time-course of acute mountain sickness. Meyer J. High Alt Med Biol; 2012 Dec 03; 13(4):281-4. PubMed ID: 23270446 [Abstract] [Full Text] [Related]
28. Association between physiological responses after exercise at low altitude and acute mountain sickness upon ascent is sex-dependent. Shen Y, Yang YQ, Liu C, Yang J, Zhang JH, Jin J, Tan H, Yuan FZ, Ke JB, He CY, Zhang LP, Zhang C, Yu J, Huang L. Mil Med Res; 2020 Nov 05; 7(1):53. PubMed ID: 33148321 [Abstract] [Full Text] [Related]
29. Risk determinants of acute mountain sickness in trekkers in the Nepali Himalaya: a 24-year follow-up. McDevitt M, McIntosh SE, Rodway G, Peelay J, Adams DL, Kayser B. Wilderness Environ Med; 2014 Jun 05; 25(2):152-9. PubMed ID: 24864065 [Abstract] [Full Text] [Related]
30. Background rates of acute mountain sickness-like symptoms at low altitude in adolescents using Lake Louise score. Dallimore J, Foley JA, Valentine P. Wilderness Environ Med; 2012 Mar 05; 23(1):11-4. PubMed ID: 22441083 [Abstract] [Full Text] [Related]
31. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Maggiorini M, Brunner-La Rocca HP, Peth S, Fischler M, Böhm T, Bernheim A, Kiencke S, Bloch KE, Dehnert C, Naeije R, Lehmann T, Bärtsch P, Mairbäurl H. Ann Intern Med; 2006 Oct 03; 145(7):497-506. PubMed ID: 17015867 [Abstract] [Full Text] [Related]
32. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM. Arch Intern Med; 2005 Feb 14; 165(3):296-301. PubMed ID: 15710792 [Abstract] [Full Text] [Related]
33. Sleeping in moderate hypoxia at home for prevention of acute mountain sickness (AMS): a placebo-controlled, randomized double-blind study. Dehnert C, Böhm A, Grigoriev I, Menold E, Bärtsch P. Wilderness Environ Med; 2014 Sep 14; 25(3):263-71. PubMed ID: 24931591 [Abstract] [Full Text] [Related]
34. Incidence of acute mountain sickness in UK Military Personnel on Mount Kenya. Hazlerigg A, Woods DR, Mellor AJ. J R Army Med Corps; 2016 Dec 14; 162(6):465-469. PubMed ID: 26604255 [Abstract] [Full Text] [Related]
35. Acute mountain sickness in children at 4380 meters in the Himalayas. Pradhan S, Yadav S, Neupane P, Subedi P. Wilderness Environ Med; 2009 Dec 14; 20(4):359-63. PubMed ID: 20030445 [Abstract] [Full Text] [Related]
36. Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial. Hillenbrand P, Pahari AK, Soon Y, Subedi D, Bajracharya R, Gurung P, Lal BK, Marahatta R, Pradhan S, Rai D, Sharma S, Birmingham Medical Research Expeditionary Society. Wilderness Environ Med; 2006 Dec 14; 17(2):87-93. PubMed ID: 16805144 [Abstract] [Full Text] [Related]
37. Flying to high-altitude destinations: Is the risk of acute mountain sickness greater? Burtscher J, Swenson ER, Hackett PH, Millet GP, Burtscher M. J Travel Med; 2023 Jun 23; 30(4):. PubMed ID: 36694981 [Abstract] [Full Text] [Related]
38. Medroxyprogesterone at high altitude. The effects on blood gases, cerebral regional oxygenation, and acute mountain sickness. Wright AD, Beazley MF, Bradwell AR, Chesner IM, Clayton RN, Forster PJ, Hillenbrand P, Imray CH, Birmingham Medical Research Expeditionary Society. Wilderness Environ Med; 2004 Jun 23; 15(1):25-31. PubMed ID: 15040503 [Abstract] [Full Text] [Related]
39. The Impact of Nocebo and Placebo Effects on Reported Incidence of Acute Mountain Sickness. Bärtsch P. High Alt Med Biol; 2022 Mar 23; 23(1):8-17. PubMed ID: 34964659 [Abstract] [Full Text] [Related]
40. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile. Moraga FA, Flores A, Serra J, Esnaola C, Barriento C. Wilderness Environ Med; 2007 Mar 23; 18(4):251-7. PubMed ID: 18076292 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]